The Tumor Genomics Market was USD 21.42 billion in 2020 and is expected to reach USD 56.54 billion in 2028 and register a revenue CAGR of 12% during the forecast period 2022-2028.
There are multiple factors that drive the tumor genomics market such as rising government initiatives, increasing number of product approvals and launches, and rising incidence cases of cancer, thus increasing the utilization of genomic techniques (such as next-generation techniques, polymerase chain reaction, microarray, in-situ hybridization, immunohistochemistry). Moreover, there are challenges that hamper the growth of the tumor genomics market including the high cost of genomic equipment, and lack of unified framework for data integration.
(Get 15% Discount on Buying this Report)
A full report of Global Tumor Genomics Market is available at: https://orionmarketreports.com/tumor-genomics-market/94474/
Market Segments
By Technique
- Next-generation Sequencing Technique (NGS)
- Polymerase Chain Reaction (PCR)
- Microarrays
- In-situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Others (Mass Spectrometry and Flow Cytometry)
By Application
- Diagnostic and Monitoring
- Drug Discovery & Development
- Biomarker Discovery
Key Players
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- QIAGEN
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Hoffman-La Roche, Ltd.
- Merck KGaA
- Pacific Biosciences of California, Inc.
- NeoGenomics Laboratories Inc.
- Myriad Genetics, Inc.
Scope of the Report
The research study analyzes the global Tumor Genomics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Tumor Genomics Market Report
1. What was the Tumor Genomics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Tumor Genomics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Tumor Genomics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Tumor Genomics market.
- The market share of the global Tumor Genomics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Tumor Genomics market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Tumor Genomics market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
